Targeting the WSB2–NOXA axis in cancer cells for enhanced sensitivity to BCL-2 family protein inhibitors
Anti-apoptotic B-cell lymphoma-2 (BCL-2) family proteins are frequently overexpressed in various cancers, playing a pivotal role in cancer initiation and progression, as well as intrinsic or acquired resistance to therapy. Although inhibitors targeting BCL-2, such as Venetoclax, have shown efficacy...
Saved in:
Main Authors: | Dongyue Jiao, Kun Chang, Jiamin Jin, Yingji Chen, Mo Ren, Yucong Zhang, Kun Gao, Yaoting Xu, Lixin Wang, Chenji Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
eLife Sciences Publications Ltd
2025-07-01
|
Series: | eLife |
Subjects: | |
Online Access: | https://elifesciences.org/articles/98372 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Combination of hypomethylating agents and inhibitor of BCL-2 in treatment of patients with relapsed acute myeloid leukemia: S.P. Botkin hospital experience
by: M. A. Granatkin, et al.
Published: (2023-03-01) -
A clinical case of the effective combined use of BCL-2 and PI3K inhibitors in the treatment of a patient with an unfavorable chronic lymphocytic leukemia with transformation into diffuse large B-cell lymphoma (Richter’s syndrome)
by: O. A. Rukavitsyn, et al.
Published: (2022-11-01) -
Ubiquitin and regulation of apoptosis in Jurkat cells
by: O. L. Nosareva, et al.
Published: (2018-09-01) -
BCL2 Expression in the Brains of Diabetic Rats Treated with Ginger
by: Mohammad Mohsen Taghavi, et al.
Published: (2025-07-01) -
VENETOCLAX IN TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA (literature review)
by: T. E. Byalik
Published: (2018-07-01)